Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
Active, not recruiting · NCT02659930 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma | AIDS, Blood-Borne Infections, DNA Virus Infections, Genital Diseases, HIV infectious disease, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Multi-centric Castleman's Disease, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, neoplasm, sarcoma, sexually transmitted disease, uterine carcinosarcoma, vascular cancer, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 1 | 2026-08-28 | NCT02659930 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |